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Abstract 
Introduction. Genistein (plant isoflavone) is a well-known anti-cancer drug with estrogenic-like properties. 
Genistein also regulates sugar and lipid metabolism; thus, it has anti-diabetic properties. The aim of the study 
was to evaluate in vitro effects of genistein on glucose transport, fatty acids oxidation, activation of PKB, and 
expression of genes related to insulin pathway in differentiated myoblast C2C12 mouse cell line. 
Material and methods. Differentiated myoblast C2C12 mouse cell line was used to assess the effects of different 
genistein concentrations on glucose transport and fatty acids oxidation measured by radioactivity technique, 
activation of PKB, and expression of selected genes related to insulin signaling pathway (IR-a, IR-b, IRS-1, PKB, 
GLUT-4, PP2A, SH-PTP2) at the mRNA and protein levels. Cells were incubated with various concentrations 
of genistein under standard conditions for 0–48 hours.
Results. Genistein in low concentrations (0.1–1 µM) significantly increased glucose transport and decreased 
fatty acids oxidation in C2C12 cells after 48 h of incubation. High concentration of genistein (50 µM) had the 
opposite effect. Genistein stimulated PKB phosphorylation during the first 5–10 minutes of incubation. There 
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was no significant impact on the protein expression of selected genes (IR-a, IR-b, IRS-1, PKB, GLUT-4, PP2A-
-Ca, ER-a and ER-b) after 48 h treatment. We observed inverse correlation between genistein concentration 
and the expression of SH-PTP2 protein. Genistein affected the expression pattern of mRNAs for genes related 
to the insulin pathway, however, not the expression of the encoded proteins. 
Conclusions. The results of this study showed that depending on the concentration and time of incubation ge-
nistein significantly affects glucose and lipid metabolism and at low concentration modifies expression pattern 
of a few genes in C2C12 cells. (Folia Histochemica et Cytobiologica 2018, Vol. 56, No. 3, 123–132)
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Introduction
Genistein (4’,5,7-trihydroxyisoflavone) is a phytoes-
trogen found in plants from Fabaceae family such as 
soybeans. It has numerous health benefits, such as 
positive regulation of homeostasis, attributed to its 
multiple biological functions [1]. The concentration 
of genistein in human and animal body fluids depends 
on the type of diet. A human diet rich in vegetable 
products (including soybean and soybean-derived 
products) significantly increases concentration of this 
phytoestrogen in the body [2].
Multiple studies suggest that dietary phytoestro-
gens play a beneficial role in reducing obesity and 
protecting against diabetes, as well as in improving 
glucose metabolism and insulin resistance [3]. In cells, 
the glucose level is regulated by insulin, the major 
hormone controlling critical cellular energy functions. 
The glucose and lipid metabolism is regulated by 
activation and regulation of the insulin cellular path-
way-associated genes including receptors and related 
proteins, i.e. insulin receptors (IRs), insulin receptor 
substrate 1 (IRS-1), phosphoinositide 3-kinase (PI-
3K) and protein kinase B (PKB) [4]. Perturbations of 
this pathway lead to development of type 2 diabetes 
that manifests by increased chronic insulin resis-
tance and the loss of function of pancreatic b-cells. 
Because of the growing incidence of type 2 diabetes 
and complications related to this widespread disease, 
the identification of effective drugs protecting b-cells 
functions is extremely important [5]. Genistein is one 
of the drugs with such a potential [6]. 
Many studies have demonstrated that genistein 
has a direct anti-diabetic effect after administration to 
animals and humans [7]. It increases b-cell proliferation 
and regeneration [8], regulates glucose-stimulated 
insulin secretion (GSIS) [9] and protects cells against 
apoptosis [10]. These effects may be independent of 
genistein functions as an estrogen receptor agonist, an-
tioxidant, or tyrosine kinase inhibitor [11, 12]. Genistein 
regulates a plethora of molecular pathways critical for 
cell homeostasis and survival. It affected i.e. activation 
of NF-kB pathway, PI3K/Akt/mTOR signaling pathway 
or MAPK/ERK pathway [13]. In low concertation (up 
to 10 µM) genistein induces cell proliferation, studied 
mainly in cancer cell lines (i.e. human breast cancer 
cell line MCF-7) [14] or human uterine leiomyoma 
[15]). Higher concertation of genistein (above 10 µM) 
significantly reduced proliferation of many cell types 
(adipocytes 3T3 L1 [16], muscle — RASMCs [17], 
endothelial cells — HCAEC [18] or epithelial cell line 
RWPE-1 [19]) and induced apoptosis [20].
The aim of the present study was to investigate 
the effects of genistein on energy metabolism, gene 
transcription profile and the expression of proteins 
related to the insulin pathway. Experiments were car-
ried out on mouse myoblast cell line C2C12, because 
these cells exhibit strong reactivity to the modification 
of glucose metabolism.
Materials and methods
The work was approved by institutional review boards and 
the State Committee for Scientific Research (KBN, Poland).
Cell culture. Experiments were performed in vitro on mouse 
C2C12 myogenic cell line obtained from the European 
Collection of Animal Cell Cultures (Porton Down, UK). 
Cells were grown in Dulbecco Modified Eagle’s Medium 
(DMEM) supplemented with 20% fetal bovine serum 
(FBS), antibiotics: penicillin-streptomycin (50 IU/mL) and 
fungizone (2.5 µg/mL) (all purchased from Life Technolo-
gies, Warsaw, Poland) in an atmosphere of 5% CO2/95% 
humidified air at 37°C. Confluent culture (about 90% of 
confluence) was differentiated in DMEM containing 2% 
of horse serum (Life Technologies) for three days. On the 
3rd day, medium was removed and cells were washed twice 
with phosphate buffered saline (PBS, Life Technologies, 
Warsaw, Poland). DMEM without serum was added for the 
next 24 h. Then the cells were washed twice with PBS and 
the experiments were commenced.
Genistein. Genistein was purchased from SigmaAldrich 
(Poznan, Poland). The stock solution was dissolved in eth-
anol (99.8%, SigmaAldrich). The working solutions were 
stored at -80°C. Used concentrations of genistein (0.1; 1 and 
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50 µM) were based on the results obtained in preliminary 
study (data not shown). 
Measurement of glucose transport. The experiment was 
performed on cells cultured in 24-well plates. Genistein 
(0-control, 0.1; 1 or 50 µM) was added to the medium 
(DMEM without FBS) for 1, 3, 6 and 48 h. Each time-point 
experiment was repeated 3 times. At each time-point me-
dium was removed, cells were rinsed twice with PBS, and 
incubated with 2-deoxy-D-[1,2-3H]-glucose (radioactivity 
277.5 Bq, Amersham, UK) in PBS. After 15 min cells were 
washed twice with PBS. Then 200 µl of 2 M NaOH was 
added. Following incubation for 24 h, 50 µl of cells lysates 
were taken for protein assay [21] and the radioactivity of 
the remaining sample was analyzed in a liquid scintillation 
counter (Packard TRI-CARB, Packard, Ramsey, MN, 
USA). Results are presented as % of control value (mean 
± SD) from 4 independent experiments.
Measurement of fatty acids oxidation. Level of b-oxidation 
was analyzed according to Manning et al. [22]. The exper-
iment was performed on cells cultured in 24-well plate. 
Genistein (0-control, 0.1; 1 or 50 µM) was added to the me-
dium (DMEM without FBS) for 1, 3, 6 and 48 hours. After 
given time of incubation medium was removed, cells were 
rinsed twice with PBS and incubated with tritium labeled 
[9,10-3H] palmitic acid (radioactivity 280.1 Bq, Amersham, 
UK) in PBS. After 60 min of incubation (37°C, 5% CO2, 
95% humidity) cells were washed twice with PBS. Then 
200 µl of 2 M NaOH was added. Following incubation for 
24 h cells were lysed. A fifty µl of the lysates were used for 
protein assay [21] and the remaining samples were trans-
ferred to AG-1-X8 column (Bio-Rad, Munich, Germany). 
The column filtrate was analyzed in a liquid scintillation 
counter (Packard TRI-CARB). The activity of b-oxidation 
in C2C12 cells was determined by the amount of tritiated 
water formed from the oxidation of ([9,10-3H] palmitic acid. 
Results are presented as percentage of control value (mean 
± SD) from 4 independent experiments. 
Western blot. The experiment was performed on cells 
cultured in 6-well plates. After genistein treatment (0, 0.1, 
1 or 50 µM) total proteins were extracted from cells using 
RIPA buffer (Sigma Aldrich) and centrifuged at 2000 g for 
20 min. Protein extracts were separated in 4–12% denaturing 
polyacrylamide gel. Proteins were blotted onto nitrocellu-
lose membrane (Life Technologies, Warsaw, Poland) and 
blocked with 5% fat-free dry milk in Tris-buffered saline 
Tween (TBST, Sigma Aldrich) at 4°C. After washing with 
TBST, proteins were incubated overnight at 4°C with prima-
ry antibodies (Santa Cruz Biotechnology, Heidelberg, Ger-
many): rabbit polyclonal IgG anti-p(ser437)Akt-1/2/3, rabbit 
polyclonal IgG anti-Akt 1/2/3, rabbit polyclonal IgG anti-IRa 
and b, rabbit polyclonal IgG SH-PTP2, rabbit polyclonal IgG 
anti-PP2A-Ca, rabbit polyclonal IgG anti-GAPDH, rabbit 
polyclonal IgG anti-IRS1, rabbit polyclonal IgG anti-ERa 
and chicken polyclonal IgG anti-ERb503 received from 
Prof. Jan-Åke Gustafsson and Dr. Margaret Warner from 
the Department of Biosciences and Nutrition, Karolinska 
Institutet, Stockholm, Sweden. The bound antibodies were 
detected by second peroxidase-conjugated antibodies: don-
key polyclonal IgG anti-rabbit HRP and rabbit polyclonal 
IgG anti-chicken HRP (Santa Cruz Biotechnology) and 
chemiluminescence (ECL detection reagent; Amersham). 
For densitometry analysis X-Ray films were scanned, and 
integrated optical density (IOD) was measured using Kodak 
1D 3.5 software (New Haven, CT, USA). The densitomet-
ric values of the investigated proteins were normalized to 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase). All 
western blots analyzes were performed at least in triplicate. 
Results are presented as % of control value (mean ± SD).
Microarray analysis. Microarray analysis was performed us-
ing SuperArray kit (Bio-Rad, Munich, Germany). Genistein 
(1 µM) was added for 4 h (short stimulation) or 24 h (long 
stimulation) to cells cultured as described above. RNA ex-
traction, cRNA and cDNA synthesis and hybridization were 
performed according to the manufacture’s protocols. Hy-
bridization results were visualized on X-ray plates, scanned 
(CanoScan Lide 60, Ōta, Tokio, Japan), and analyzed in 
GEArray Expression Analysis Suite (SuperArray software, 
available on the manufacturer’s website SABiosciences 
Corp., Frederick, MD, USA). The densitometry values 
of the investigated genes were normalized to GAPDH, 
rps27a (ribosomal protein S27a) and b2m (b-2 microglob-
ulin), hsp90ab1 (heat shock protein 90 kDa a — cytosolic, 
class B member 1) and ppia (peptidylprolyl isomerase A). 
Based on this study we compiled the list of genes which 
expression was changed at least 100% comparing to the 
control values.
Statistical analysis. The significance of the difference was 
assessed by parametric t-test for a normal distribution of 
values and Kruskal-Wallis test for a non-parametric distri-
bution of values (GraphPad Prism 4 software, La Jolla, CA, 
USA). P values < 0.05 were considered significant. 
Results
Glucose transport in differentiated myoblast C2C12 
cell line
We examined the effects of genistein (Gen) on the intra-
cellular glucose transport. Genistein at 50 µM concen-
tration, but not at lower concentrations, caused dramat-
ic (~85%) reduction of glucose transport (p < 0.001) 
regardless of the incubation time (Fig. 1). Incubation 
of cells for 6 h with 1 µM genistein stimulated slight-
ly glucose transport (108.4%, p < 0.05), while the 
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values obtained for the 0.1 µM genistein fluctuated 
near the control values with a slight decrease (92.3%, 
p < 0.05) after incubation for 3 h (Fig. 1). After 48 h 
of incubation these two concentrations caused a slight 
10% (Gen 0.1 µM, p < 0.05; Gen 1 µM, p < 0.001) 
increase in glucose uptake (Fig. 1).
Fatty-acids b-oxidation in differentiated myoblast 
C2C12 cell line
We tested the effect of genistein on fatty acids oxida-
tion. One-hour incubation of differentiated myoblast 
C2C12 cell line with 50 µM genistein increased b-ox-
idation by 34.4%, p < 0.001). This effect dissipated 
with time of incubation: 115.2% after 3 hours and 
83.8% after 6 hours (Fig. 2). After 48 h of incubation 
with genistein there was a dose-dependent reduction 
in the b-oxidation activity: 0.1 µM — 73.9% (p < 
< 0.001), 1 µM — 92.1% (p < 0.05) and 50 µM — 97.8% 
(p > 0.05) relative to the control value (Fig. 2). 
Effects of genistein on insulin signaling  
pathways proteins
Protein kinase B (PKB) is one of the major proteins 
of the insulin pathway, which regulates cell response 
to the glucose level. One µM genistein caused a very 
rapid and significant increase (by 40%, p < 0.01) in 
the PKB kinase phosphorylation level during the first 
15 min of incubation. This effect disappeared after 
30 min of incubation (Fig. 3).
There were no significant changes in the expression 
level of the other studied insulin pathway proteins, i.e. 
insulin receptor IR-beta, IRS-1 or PKB kinase when 
cells were incubated with 0.1, 1 and 50 µM genistein 
(Suppl. Fig. 1A, C, D). There was also no effect of ge-
nistein (0.1, 1 and 50 µM) on the expression of IR re-
ceptors (Suppl. Fig. 1A, B), GLUT-4 (Suppl. Fig. 1E) 
and estrogen receptors (ER-a and ER-b, Suppl. 
Fig. 1F, G) in differentiated myoblast C2C12 cell line. 
Results from western blot analysis revealed that 
genistein caused no change in the expression of the 
phosphatase PP2A-Ca. Only at 50 µM concentration, 
genistein increased PP2A-Ca expression by 20% 
after 48 h incubation (Suppl. Fig. 1H). In contrast, 
there was a positive correlation between the genistein 
concentration and expression of SH2 protein tyrosine 
phosphatase 2 (SH-PTP2) (Suppl. Fig. 1I).
Effects of genistein on gene expression pattern
Microarray analysis was focused on 119 genes related 
to insulin signaling pathway. The analysis of genes’ 
expression in the control conditions after 4 and 24 h 
incubation of the differentiated myoblast C2C12 cell 
line with the genistein revealed only slight effects 
(Table 1). Addition of 1 µM genistein for 4 h caused 
increase in the expression of 21 genes, among which 
the 11 genes were activated by genistein (not detected 
in control condition, Table 2). Only one gene (nck1, 
Table 2) showed reduced expression. Genistein-af-
fected genes belonged to the following families 
and pathways: insulin receptor family, PI-3 kinase 
pathway, MAPK kinase pathway, insulin pathway, 
carbohydrate metabolism, lipid metabolism, transcrip-
Figure 1. Genistein effect on the glucose uptake by differentiated myoblast C2C12 cell line. Genistein (0.1, 1 and 50 µM) was 
added on the 4th day of cell differentiation for 1, 3, 6 or 48 hours. Glucose transport was measured as described in Methods. 
The results are shown as the mean values ± SD. Statistical differences were calculated relative to the values obtained for 
control. *P < 0.05; ***P < 0.001.
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tion factors and regulatory genes of the cell cycle or 
differentiation. Incubation of the cells for 24 h in the 
presence of 1 µM genistein resulted in significantly 
less-pronounced effects on the insulin pathway genes 
expression. There was reduction in the expression of 
three genes: cbl, gck, sorbs1, and the increased expres-
sion of akt1gene. Results of microarray analysis are 
shown in Table 2.
Disscusion
Comparison between populations of Asian and 
Western developed countries showed that a diet rich 
in phytoestrogens reduces the incidence of cardio-
vascular diseases and disorders of the carbohydrate 
and lipid metabolism [23]. Similar health effects were 
observed for a diet rich in soy-based foods; it caused 
Figure 2. Genistein effect on b-oxidation of fatty acids in differentiated myoblast C2C12 cell line. Genistein (0.1, 1 and 
50 µM) was added on the 4th day of differentiation and cells were incubated for 1, 3, 6 or 48 hours. b-oxidation of fatty acids 
was measured as described in Methods. The results are presented as the mean values ± SD. Statistical differences were 
calculated relative to the control values. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 3. Western blot analysis of the effects of 1 µM genistein and time of incubation (0–45 minutes) on the p(ser437)Akt-
1/2/3 kinase level in differentiated myoblast C2C12 cell line. Results are presented as mean ± SD. Statistical differences were 
calculated relative to the values obtained for control. *P < 0.05; ***P < 0.001. The densitometry values were normalized to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression levels. PKB — protein kinase B. 
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a decrease in total cholesterol, low-density lipopro-
tein (LDL) and triglycerides without modification 
of high-density lipoprotein (HDL) concentration in 
serum of postmenopausal women [24]. Studies on 
male CD-1 mice also confirmed positive effects of 
soy products on animal health. Soy-containing diet 
caused reduction in serum insulin level, pancreat-
ic insulin content, AMP-activated protein kinase 
(AMPK) phosphorylation, activated expression of 
genes responsible for the fatty acids oxidation (in 
the adipose tissue) and increased glucose transport 
activity in muscle cells [25]. It has been shown in mice 
that soy-enhanced diet prevented obesity and related 
disorders [26]. 
Genistein is one of the most active soy isoflavones. 
It is involved in the regulation of lipid and glucose 
metabolism, but the exact role, the mechanism of 
action and the degree of its positive health impact are 
poorly understood. Genistein is structurally similar to 
17b-estradiol, which allows its binding to the estro-
gen receptors and the activation of protein kinase A 
(PKA) [27]. Our previous studies on differentiated 
myoblast C2C12 cell line showed that 10 nmol of 
17 b-estradiol significantly affected the expression 
of genes related to the insulin pathway [28]. This 
study suggested that genistein might affect sugar and 
lipid metabolism through interactions with estrogen 
receptors. There are also reports indicating a non-es-
trogenic effect of genistein. The studies of Liu et al. 
[12] showed that genistein regulated the secretion of 
insulin in two insulin-secreting cell lines INS-1 and 
MIN6, through the signal cascade closely related to 
the cAMP activation. Genistein increased intracellu-
lar cAMP level and activated PKA by a mechanism 
unrelated to estrogen receptor or protein tyrosine 
kinase (PTK) but associated with the stimulation of 
adenylate cyclase activity.
It has been also suggested that genistein may mod-
ulate the activity of glucose transport at the cellular 
level. Our results obtained in the present studies are 
consistent with the results of Shuo-Bin et al. [29] stud-
ies on C2C12 cells. We showed that 50 µM genistein 
caused inhibition (approximately by 85%) of glucose 
uptake. We also showed that low doses of genistein 
had only slight but statistically significant effect on 
glucose transport in C2C12 cells (± 10% change) 
both after short (1–6 h) and long (48 h) incubation 
(Fig. 1). Similar results were obtained by Nomura et 
al. [30]. In their studies the 1 h incubation with low 
concertation (1–5 µM) of genistein did not affect 
Table 1. Differences in insulin pathway gene expression in differentiated myoblast C2C12 cell line after 4 and 24 h incubation 
in control condition. Underlined are genes with switched on expression after 24 h; “≠” — genes with increased expression; 
“Ø” — genes with decreased expression. Information of gene functions is quoted according to the UniProtKB database
Gene expression in control condition (after 4 and 24 hour incubation) 
Gene symbol Gene name Function Expression level
bcl2l1 Acetyl-Coenzyme A  
carboxylase 2
Catalyzes the ATP-dependent carboxylation of acetyl-CoA to 
malonyl-CoA; inhibition of fatty acid and glucose oxidation; 
regulation of mitochondrial fatty acid oxidation through malo-
nyl-CoA-dependent inhibition of carnitine palmitoyltransferase 1
≠2.58 
Cbl Casitas B-lineage lymphoma Proto-oncogene ≠2.76
dok4 Docking protein 4 Transmembrane receptor protein tyrosine kinase signaling 
pathway (MAPK)
≠2.16
g6pdx Glucose-6-phosphate dehy-
drogenase X-linked
Catalase oxidative pentose-phosphate pathway ≠2.33
map2k2 Mitogen activated protein 
kinase kinase 2
Protein serine/threonine kinase activity; MAPK  
signaling pathway
≠2.72
Rras Harvey rat sarcoma oncogene, 
subgroup R
Regulates the organization of the actin cytoskeleton with  
OSPBL3; modulates integrin beta-1 (ITGB1) activity
≠2.41
slc27a4 Solute carrier family 27 (fatty 
acid transporter), member 4
Involved in translocation of long-chain fatty acids (LFCA) across 
the plasma membrane; the principal fatty acid transporter in 
small intestinal enterocytes; formation of the epidermal barrier; 
required for fat absorption in early embryogenesis
≠2.22
sorbs1 Sorbin and SH3 domain 
containing 1
Tyrosine phosphorylation of CBL by linking CBL to the insulin 
receptor; required for insulin-stimulated glucose transport. 
Involved in formation of actin stress fibers and focal adhesions
≠2.38
Abbreviations: CBL (Casitas B-lineage Lymphoma) — E3 ubiquitin-protein ligase involved in cell signaling and protein ubiquitination; LFCA — long-chain 
fatty acids
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Table 2. Effect of genistein on the insulin pathway gene expression in differentiated myoblast C2C12 cell line after 4 h and 
24 h incubation. Underlined are genes with switched on expression compare to the appropriate control condition (4 h or 
24 h); “≠” — genes with increased expression; “Ø” — genes with decreased expression. Information on gene functions is 
quoted according to the UniProtKB database
Gene symbol Gene name Function Expression level
List of gene expressed after 4 hours of cell incubation with 1 µM genistein
acacb Acetyl-Coenzyme A  
carboxylase 2
Catalyzes ATP-dependent carboxylation of acetyl-CoA to malo-
nyl-CoA; inhibition of fatty acid and glucose oxidation; regulation 
of mitochondrial fatty acid oxidation through malonyl-CoA-de-
pendent inhibition of carnitine palmitoyltransferase 1
≠2.61
acox1 Acyl-Coenzyme A oxidase 1, 
palmitoyl
Catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs ≠2.26
aebp1 AE binding protein 1 Regulates MAP-kinase activity in adipocytes; regulates NF-kB 
activity in macrophages; transcriptional repressor
≠3.98
akt2 Thymoma viral proto-onco-
gene 2
Related to serine/threonine-protein kinase; regulates metabolism, 
proliferation, cell survival, growth and angiogenesis
≠3.34
araf Serine/threonine-protein  
kinase A-Raf
Transduction of mitogenic signals from the cell membrane to the 
nucleus; regulates the TOR signaling cascade
≠2.77
cap1 CAP, adenylate cyclase- 
-associated protein 1
Regulates filament dynamics; implicated in complex  
developmental processes, including mRNA localization  
and the establishment of cell polarity
≠2.04
cbl Casitas B-lineage lymphoma Proto-oncogene ≠4.06
cebpb CCAAT/enhancer binding 
protein (C/EBP), beta
DNA binding; regulation of transcription ≠2.55
cebpd CCAAT/enhancer binding 
protein (C/EBP), delta
Transcription factor regulating the expression of genes involved 
in immune and inflammatory responses 
≠2.27
dok4 Docking protein 4 Transmembrane receptor protein tyrosine kinase signaling path-
way (MAPK)
≠4.34
g6pdx Glucose-6-phosphate  
dehydrogenase X-linked
Catalase oxidative pentose-phosphate pathway ≠5.28
hk2 Hexokinase 2 Involved in the metabolism of hexoses ≠2.71
klf10 Kruppel-like factor 10 Regulates the circadian expression of genes involved in  
lipogenesis, gluconeogenesis, and glycolysis in the liver
≠2.01
map2k1 Mitogen activated protein 
kinase kinase 1
Protein serine/threonine kinase activity, MAPK  
signaling pathway
≠3.35
map2k2 Mitogen activated protein 
kinase kinase 2
Protein serine/threonine kinase activity, MAPK  
signaling pathway
≠4.19
nck1 Non-catalytic region of tyrosine 
kinase adaptor protein 1
Adapter protein which associates with tyrosine-phosphorylated 
growth factor receptors
Ø0.46
Ptprf Protein tyrosine phosph-atase, 
receptor type, F
Transmembrane receptor protein tyrosine phosphatase signaling 
pathway; role in cell adhesion
≠2.54
raf1 V-raf-leukemia viral  
oncogene 1
Protein serine/threonine kinase activity; Cell growth and/or main-
tenance; Regulation of cell cycle
≠2.41
rras Harvey rat sarcoma oncogene, 
subgroup R
Regulates the organization of the actin cytoskeleton with OSP-
BL3; modulates integrin b-1 (ITGB1) activity
≠2.02
rras2 Related RAS Viral (R-Ras) 
Oncogene Homolog 2
A plasma membrane-associated GTP-binding protein with  
GTPase activity; transduces growth inhibitory signals across the 
cell membrane exerting its effect via an effector shared with the 
Ras proteins but in an antagonistic fashion
≠3.09
slc27a4 Solute carrier family 27 (fatty 
acid transporter), member 4
Involved in translocation of long-chain fatty acids (LFCA) across 
the plasma membrane; the principal fatty acid transporter in 
small intestinal enterocytes; formation of the epidermal barrier; 
required for fat absorption during early embryogenesis
≠2.07
sorbs1 Sorbin and SH3 domain  
containing 1
Involved in tyrosine phosphorylation of by linking CBL to the  
insulin receptor; required for insulin-stimulated glucose transport; 
involved in formation of actin stress fibers and focal adhesions
≠3.20
Æ
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Table 2 (cont.). Effect of genistein on the insulin pathway gene expression in differentiated myoblast C2C12 cell line after 
4 h and 24 h incubation. Underlined are genes with switched on expression compare to the appropriate control condition 
(4 h or 24 h); “≠” — genes with increased expression; “Ø” — genes with decreased expression. Information on gene functions 
is quoted according to the UniProtKB database
Gene symbol Gene name Function Expression level
List of genes expressed after 24 hours of cell incubation with 1 µM genistein 
akt1 serine/threonine-protein 
kinase1
Regulates many processes including metabolism, proliferation, 
cell survival, growth and angiogenesis
≠2.30
cbl Casitas B-lineage lymphoma Proto-oncogene that encodes a RING finger E3 ubiquitin ligase. 
The encoded protein is one of the enzymes required for targeting 
substrates for degradation by the proteasome
Ø0.37
gck Glucokinase Catalyzes the initial step in utilization of glucose by the beta-cell 
and liver at physiological glucose concentration
Ø0.45
sorbs1 Sorbin and SH3 domain  
containing 1
Involved in tyrosine phosphorylation of CBL by linking CBL 
to the insulin receptor; required for insulin-stimulated glucose 
transport; involved in formation of actin stress fibers and focal 
adhesions 
Ø0.39
Abbreviations as in the description of Table 1.
glucose uptake in mouse MC3T3-G2/PA6 cells differ-
entiated into mature adipocytes. Higher concertation 
of genistein (10 µM) significantly decreased glucose 
uptake and this inhibitory effect was not reversed by 
addition of insulin. We also observed similar corre-
lation; genistein at low concentration did not affect 
insulin-stimulated glucose uptake; however, at high 
concentration (50 µM) it inhibited insulin-stimulated 
glucose transport (our unpublished data). Nomura 
et al. [30] also showed that genistein (10 µM) had no 
effect on insulin-stimulated phosphorylation of PKB. 
Also Bazuine et al. [31] showed in 3T3-L1 adipocytes 
that the higher genistein concentration (above 20 µM) 
caused inhibition of glucose uptake, which was in-
dependent of protein kinase PKB inhibition. These 
authors concluded that genistein affected function 
of proteins such as the GLUT4 transporter and that, 
in 3T3-L1 adipocytes, genistein is a potent and di-
rect inhibitor of GLUT-4 insulin-stimulated glucose 
uptake [31]. Another study showed that the effect 
of genistein in 3T3-L1 adipocytes was unrelated to 
insulin-stimulated GLUT4 translocation from the 
low-density microsomes to the plasma membrane 
[32]. Authors suggested that observed effect might 
be related to the decrease in the intrinsic activity 
of the glucose uptake by conformational change of 
GLUT-4 transporter. Interestingly, we found that high 
concentration of genistein (50 µM) adversely affected 
energy metabolism in C2C12 cells. It also enhanced 
fatty acids metabolism during a short-term period (1–3 
hours) of incubation. This observation may explain 
a positive therapeutic effect of genistein on human 
obesity and diabetes [6]. We think that the inhibitory 
effect of 50 µM genistein on the glucose uptake can 
be related to the increased level of membrane phos-
phatase SH-PTP2 responsible for muting the signal 
from induced insulin receptor. This phosphatase may 
play a role in the inhibition of the glucose transport by 
genistein, because its cell content increased parallely 
to increased genistein concentration. 
In addition, some in vitro studies have demonstrat-
ed positive effects of genistein on glucose transport 
in the C2C12 cells (stimulation of about 100%, at 
concentrations from 0.01 to 100 µM) that was asso-
ciated with the increased phosphorylation level of the 
insulin receptor substrate IRS-1 [29]. Genistein also 
increased the Akt phosphorylation level in aged rats, 
which may be related to the increase in the upstream 
interaction of ERb with p85a protein [6]. We observed 
that the C2C12 cells incubated with 0.1 µM genistein 
showed about 10% increase in glucose transport and 
50% increase in the amount of GLUT4 protein at 
the cell membrane (data not showed). In contrast, 
the high concentration of genistein (50 µM) resulted 
in 85% decrease in C2C12 cells growth rate and re-
duction in the amount of GLUT4 protein at the cell 
membrane after insulin stimulation (15 min, 100 nM 
concentration). Also Wang et al. [1] showed that in 
adipoyctes (3T3-L1 cells) genistein had antiglycemic 
properties associated with the activation of AMPK 
and induction of GLUT4 translocation to the cell 
membrane. 
Our results demonstrated that 1 µM genistein 
rises PKB kinase activity by about 40% as compared 
to the control, but only during the first 10 to 15 min 
of incubation. The observed effect was not associated 
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with the increase in glucose transport. The studies 
on mouse cell line MC3T3-G2/PA6 showed that 1 h 
incubation with 10 µM genistein has no effect on the 
inhibition of insulin-stimulated proteins phosphoryl-
ation: beta-IR, IRS-1 and Akt [30]. This suggests that 
the inhibition of glucose transport caused by genistein 
concentrations higher than 1 µM does not depend on 
the phosphorylation of insulin pathway kinases.
Our microarray studies showed no significant 
changes in the level of mRNAs of the above-described 
proteins associated with insulin signaling pathway. We 
observed that genistein treatment resulted in differ-
ent gene expression activation profile than estradiol 
treatment and modulated the expression level of 
insulin pathway genes to the lower extent than estra-
diol [28]. This may suggest that genistein regulates 
the insulin pathway protein levels by different mode 
of action than estradiol. It is also of interest that the 
24 hours incubation with 1 µM genistein reduced the 
mRNAs levels of glucokinase (GCK) and Sorbs1, and 
increased mRNA level of kinase Akt1. The Sorbs1 
protein is related to the regulation of cell response to 
insulin and its mutation causes insulin resistance [33]. 
In turn, glucokinase regulates carbohydrate metabo-
lism in response to rising or falling levels of glucose 
[34]. Moreover, it has been shown that genistein is 
a potent alpha-glucosidase inhibitor [35]. 
In conclusion, genistein, depending on concentra-
tion, causes different biological effects in C2C12 cells. 
High concentrations strongly decreased glucose trans-
port and cell proliferation as showed by us previously 
but did not affect b-oxidation of fatty acids. Results 
obtained in the present study indicate that genistein 
(at a low concertation of 1 µM) may modulate glucose 
and lipid metabolism by two independent modes of 
action. The first would be a direct stimulation of dif-
ferent cell receptors (i.e. Insulin-like Growth Factor 
receptor [36] or estrogen receptors [37, 38]) — after 
short stimulation there is a time-dependent increase 
in PKB phosphorylation and the stimulation of fatty 
acids metabolism. The second mode, a long-term 
stimulatory effect, would be related to the modula-
tion at the transcriptional level expression of genes 
associated with insulin signaling pathway. Further 
detailed studies on these two modes of regulation 
may help to develop genistein-based anti-obese and 
anti-diabetic therapies.
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